NewsBenzingaPerché le azioni di Aytu Biopharma stanno salendo del 43%; ecco 20 titoli in movimento nel premarket Perché le azioni di Aytu Biopharma stanno salendo del 43%; ecco 20 titoli in movimento nel premarket Benzinga 2026.11.17 09:30 (GMT+0) Open on Benzinga Other news Opinion: It’s not too late to add U.S. energy companies to your 401(k). They’ve been making out like bandits. Worried investors are paying a premium for these stocks — some with as much as 49% upside, analysts say The good news: Bubble predictions vastly outnumber actual episodes. The bad: There may be a 97% chance of one, right now. Walmart’s Winning Combo: Thrifty Shoppers and Wary AI Investors The S&P 500 just broke a crucial support level. Here’s what history shows may happen now. Want to earn 5% on shorter-term Treasurys again? Watch for this shift.
Opinion: It’s not too late to add U.S. energy companies to your 401(k). They’ve been making out like bandits.
Worried investors are paying a premium for these stocks — some with as much as 49% upside, analysts say
The good news: Bubble predictions vastly outnumber actual episodes. The bad: There may be a 97% chance of one, right now.